AMETEK Raises 2026 Guidance to $8.57 EPS on Record Q3

AMETEK Inc. (NYSE: AME) reported record third quarter 2026 results on 3 November 2026, with sales of $2.22 billion and adjusted diluted earnings of $2.21 per share, both quarterly records. Sales rose 17% from the third quarter of 2025, while adjusted EPS climbed 17% over the same period. The industrial technology company also raised its full-year 2026 adjusted EPS guidance to a range of $8.53 to $8.57, up from a prior range of $8.20 to $8.30. GAAP diluted earnings per share were $1.85.

Context — why the guidance raise matters now

The guidance increase is the central event. AMETEK had previously told investors to expect $8.20 to $8.30 per diluted share for full-year 2026. The new range of $8.53 to $8.57 sits roughly 4% above the top of that prior band and implies growth of about 15% over the company's full-year 2025 results, according to the company's own framing.

The company attributed the raise to three stated drivers: its third quarter performance, its fourth quarter outlook, and the expected contribution from the acquisition of Indicor Instrumentation. AMETEK said it completed that acquisition during the third quarter, describing the target as a group of highly differentiated industrial technology businesses. The company did not disclose the purchase price or other transaction terms.

The balance sheet shows the footprint of that deal. Goodwill rose to $10.21 billion at 30 September 2026 from $7.17 billion at 31 December 2025, an increase of about $3.04 billion. Long-term debt, net, climbed to $6.03 billion from $1.07 billion over the same nine months, while short-term borrowings and the current portion of long-term debt fell to $639.8 million from $1.21 billion. Total assets reached $22.39 billion against $16.07 billion at year-end 2025.

That mix matters for how the quarter should be read. Organic sales growth and acquisitions both contributed to the top line, and the company separated the two when discussing margins. AMETEK reported adjusted core operating margin expansion of 110 basis points, a measure it adjusts for the dilutive impact of acquisitions completed in the last twelve months and for foreign exchange. Without those adjustments, adjusted operating margin was 26.8%, up 60 basis points year over year.

Data — what the numbers show

The quarter's headline figures all set records. Net sales of $2.22 billion compared with $1.89 billion in the third quarter of 2025. GAAP operating income was $584.9 million, and adjusted operating income rose 20% to $594.7 million. Net income was $426.3 million, or $1.85 per diluted share, against $371.4 million and $1.60 a year earlier.

The two reporting segments both grew. Electronic Instruments Group sales were $1.44 billion, up 16%, with GAAP segment operating income of $406.7 million and adjusted operating income up 15% to $414.6 million. Electromechanical Group sales were $778.0 million, up 20%, with GAAP segment operating income of $210.0 million and adjusted operating income up 29% to $212.0 million.

Metric	Q3 2026	Q3 2025
Net sales	$2.22bn	$1.89bn
GAAP operating income	$584.9m	$488.4m
Adjusted operating margin	26.8%	26.2%
GAAP diluted EPS	$1.85	$1.60
Adjusted diluted EPS	$2.21	$1.89
Operating cash flow	$560.6m	$440.9m

Cash generation was the standout. Operating cash flow rose 27% to $560.6 million, and free cash flow reached $527.4 million after $33.2 million of capital expenditures. Free cash flow to net income conversion was 124%, up from 113% a year earlier. The company also reported nine-month sales of $6.19 billion, up from $5.40 billion, and nine-month diluted EPS of $5.36 versus $4.67.

Analysis — what it means for markets and sectors

The results place AMETEK in a small group of industrial technology names still converting revenue growth into margin expansion while integrating acquisitions. Core margin expansion of 110 basis points on the consolidated level, and 210 basis points in EMG, indicates the company is holding pricing and mix even as deal-related dilution works through the reported numbers.

The capital structure is the counter-argument. Long-term debt, net, rose by roughly $4.96 billion in nine months, and interest expense nearly doubled to $39.8 million in the quarter from $22.5 million a year earlier. Nine-month interest expense was $90.8 million against $58.4 million. That drag is visible in the gap between operating income growth and pre-tax income growth, and it means the Indicor contribution has to keep scaling to justify the use taken on.

Tickers exposed to this read-through include industrial technology and instrumentation peers, along with the broader S&P 500, of which AMETEK is a component. Suppliers and distributors tied to aerospace, energy and process automation end markets would see demand signals from the segment commentary, though the company did not break out end-market revenue.

Positioning is likely to hinge on the fourth quarter print rather than the third. The company's own fourth quarter adjusted EPS guidance of $2.26 to $2.30 implies 12% to 14% growth, a step below the 17% delivered in the third quarter. That deceleration is the number desks will underwrite, and it explains why the guidance raise, while meaningful, lands in a narrow band rather than a step change.

Outlook — what to watch next

AMETEK said it expects fourth quarter 2026 overall sales to be up in the low 20% range versus the fourth quarter of 2025, and full-year sales to be up mid-teens on a percentage basis. The company webcast its third quarter investor call on 3 November 2026 at 8:30 AM ET, with an archived version available in the investors section of its website.

The next hard catalyst is the fourth quarter and full-year 2026 results, which the company has not yet scheduled. Between now and then, watch whether EMG's 20% sales growth holds once the Indicor contribution annualizes, and whether interest expense stabilizes now that short-term borrowings have been reduced by roughly $569 million since year-end.

Investors should also track the acquisition integration costs that AMETEK excludes from adjusted figures. Those costs were $9.8 million in the third quarter within operating income, plus $18.1 million recorded in other income and expense. For the full year, the company's guidance reconciliation assumes $0.24 per share of acquisition-related costs, based on actual year-to-date adjustments.

Frequently Asked Questions

What does AMETEK's guidance raise mean for retail investors?

It means the company now expects full-year 2026 adjusted diluted earnings of $8.53 to $8.57 per share, versus a prior range of $8.20 to $8.30. That is the company's own expectation, not a guarantee. The raise reflects third quarter results, the fourth quarter outlook, and the Indicor Instrumentation acquisition. Adjusted figures exclude acquisition-related intangible amortization and transaction and integration costs, so they differ from GAAP earnings.

Why did AMETEK's adjusted earnings differ from GAAP earnings?

GAAP diluted earnings were $1.85 per share in the third quarter, while adjusted earnings were $2.21. The $0.36 difference reflects non-cash, after-tax amortization of acquisition-related intangible assets and acquisition transaction and integration costs. AMETEK excludes these because it does not consider them indicative of ongoing operational performance. Investors should note adjusted measures are not a substitute for GAAP figures.

What happens next for AMETEK stock?

AMETEK has not announced a date for its fourth quarter earnings release. The company guided fourth quarter adjusted EPS to $2.26 to $2.30, implying 12% to 14% growth. It also expects fourth quarter sales up in the low 20% range. Until those results land, the key variables are integration progress on Indicor Instrumentation and whether segment margin expansion continues at the third quarter's pace.

Bottom Line

AMETEK raised full-year 2026 adjusted EPS guidance to $8.53-$8.57 after a record quarter, but the implied fourth quarter growth slowdown is the number to watch.

Disclaimer: This article is for informational purposes only and does not constitute investment advice. CFD trading carries high risk of capital loss.